Mn-SOD and cuZn-SOD polymorphisms and interactions with risk factors in gastric cancer

World Journal of Gastroenterology

Volumn 16, Issue 37, 2010, Pages 4738-4746

  Yi, Jian Feng ^a   Li, Yu Min ^a   Liu, Tao ^a   He, Wen Ting ^a   Li, Xun ^a   Zhou, Wen Ce ^a   Kang, Shi Liang ^a   Zeng, Xiang Ting ^a   Zhang, Jun Qiang ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

Copper zinc superoxide dismutase; Gastric cancer; Gastric precancerous lesions; Gene polymorphisms; Interaction; Manganese superoxide dismutase

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; GENOMIC DNA; MANGANESE SUPEROXIDE DISMUTASE;

ADULT; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; ATROPHIC GASTRITIS; CANCER RISK; CHINESE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRECANCER; RISK ASSESSMENT; RISK FACTOR; STOMACH CANCER; STOMACH LESION; STOMACH POLYP; STOMACH ULCER;

EID: 77957723632     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i37.4738     Document Type: Article

References (43)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108
2. Monari M, Trinchero A, Calabrese C, Cattani O, Serrazanetti GP, Foschi J, Fabbri A, Zahlane D, Di Febo G, Tonini V, Cervellera M, Tosi MR, Tugnoli V. Superoxide dismutase in gastric adenocarcinoma: is it a clinical biomarker in the development of cancer? Biomarkers 2006; 11: 574-584
3. Wang J, Lü YY. Mitochondrial DNA 4977-bp deletion correlated with reactive oxygen species production and manganese superoxidedismutase expression in gastric tumor cells. Chin Med J (Engl) 2009; 122: 431-436
4. Pan JS, Hong MZ, Ren JL. Reactive oxygen species: a double- edged sword in oncogenesis. World J Gastroenterol 2009; 15: 1702-1707
5. Yildirim Z, Kiliç N, Ozer C, Babul A, Take G, Erdogan D. Effects of taurine in cellular responses to oxidative stress in young and middle-aged rat liver. Ann N Y Acad Sci 2007; 1100: 553-561
6. Pan JS, He SZ, Xu HZ, Zhan XJ, Yang XN, Xiao HM, Shi HX, Ren JL. Oxidative stress disturbs energy metabolism of mitochondria in ethanol-induced gastric mucosa injury. World J Gastroenterol 2008; 14: 5857-5867
7. Kang D, Lee KM, Park SK, Berndt SI, Peters U, Reding D, Chatterjee N, Welch R, Chanock S, Huang WY, Hayes RB. Functional variant of manganese superoxide dismutase (SOD2 V16A) polymorphism is associated with prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer study. Cancer Epidemiol Biomarkers Prev 2007; 16: 1581-1586
8. Czeczot H, Scibior D, Skrzycki M, Podsiad M. [Antioxidant barrier in patients with gastric cancer--preliminary study] Pol Merkur Lekarski 2005; 19: 521-525
9. Hwang TS, Choi HK, Han HS. Differential expression of manganese superoxide dismutase, copper/zinc superoxide dismutase, and catalase in gastric adenocarcinoma and normal gastric mucosa. Eur J Surg Oncol 2007; 33: 474-479
10. Monari M, Foschi J, Calabrese C, Liguori G, Di Febo G, Rizzello F, Gionchetti P, Trinchero A, Serrazanetti GP. Implications of antioxidant enzymes in human gastric neoplasms. Int J Mol Med 2009; 24: 693-700
11. Con SA, Takeuchi H, Con-Chin GR, Con-Chin VG, Yasuda N, Con-Wong R. Role of bacterial and genetic factors in gastric cancer in Costa Rica. World J Gastroenterol 2009; 15: 211-218
12. Ponder BA. Cancer genetics. Nature 2001; 411: 336-341
13. Mitrunen K, Sillanpää P, Kataja V, Eskelinen M, Kosma VM, Benhamou S, Uusitupa M, Hirvonen A. Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk. Carcinogenesis 2001; 22: 827-829
14. Cai Q, Shu XO, Wen W, Cheng JR, Dai Q, Gao YT, Zheng W. Genetic polymorphism in the manganese superoxide dismutase gene, antioxidant intake, and breast cancer risk: results from the Shanghai Breast Cancer Study. Breast Cancer Res 2004; 6: R647-R655
15. Cebrian A, Pharoah PD, Ahmed S, Smith PL, Luccarini C, Luben R, Redman K, Munday H, Easton DF, Dunning AM, Ponder BA. Tagging single-nucleotide polymorphisms in antioxidant defense enzymes and susceptibility to breast cancer. Cancer Res 2006; 66: 1225-1233
16. Oestergaard MZ, Tyrer J, Cebrian A, Shah M, Dunning AM, Ponder BA, Easton DF, Pharoah PD. Interactions between genes involved in the antioxidant defence system and breast cancer risk. Br J Cancer 2006; 95: 525-531
17. Hung RJ, Boffetta P, Brennan P, Malaveille C, Gelatti U, Placidi D, Carta A, Hautefeuille A, Porru S. Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk. Carcinogenesis 2004; 25: 973-978
18. Martin RC, Lan Q, Hughes K, Doll MA, Martini BD, Lissowska J, Zatonski W, Rothman N, Hein DW. No apparent association between genetic polymorphisms (-102 C>T) and (-9 >C) in the human manganese superoxide dismutase gene and gastric cancer(1). J Surg Res 2005; 124: 92-97
19. Martin RC, Li Y, Liu Q, Jensen NS, Barker DF, Doll MA, Hein DW. Manganese superoxide dismutase V16A single nucleotide polymorphism in the mitochondrial targeting sequence is associated with reduced enzymatic activity in cryopreserved human hepatocytes. DNA Cell Biol 2009; 28: 3-7
20. IARC. Working Group on the evaluation of carcinogenic risk to humans infection with Helicobacter pylori. In: IARC, editor. IARC monograph on the evaluation of carcinogenesis risks to humans. IARC Scientific Publications No. 61. Lyon: IARC, 1994: 177-241
21. Fox JG, Wang TC. Inflammation, atrophy, and gastric cancer. J Clin Invest 2007; 117: 60-69
22. Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R. Helicobacter pylori virulence and genetic geography. Science 1999; 284: 1328-1333
23. Gebert B, Fischer W, Weiss E, Hoffmann R, Haas R. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 2003; 301: 1099-1102
24. Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M, Hatakeyama M. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 2002; 295: 683-686
25. Park JH, Kim TY, Jong HS, Kim TY, Chun YS, Park JW, Lee CT, Jung HC, Kim NK, Bang YJ. Gastric epithelial reactive oxygen species prevent normoxic degradation of hypoxiainducible factor-1alpha in gastric cancer cells. Clin Cancer Res 2003; 9: 433-440
26. Bulbuloglu E, Inanc F, Bakaris S, Kantarceken B, Cetinkaya A, Cag̈lar R, Ilhami TK, Kilinc M. Association of adenosine deaminase, superoxide dismutase, and catalase activities with Helicobacter pylori. Dig Dis Sci 2005; 50: 2296-2299
27. Götz JM, Thio JL, Verspaget HW, Offerhaus GJ, Biemond I, Lamers CB, Veenendaal RA. Treatment of Helicobacter pylori infection favourably affects gastric mucosal superoxide dismutases. Gut 1997; 40: 591-596
28. Moss SF, Sordillo EM, Abdalla AM, Makarov V, Hanzely Z, Perez-Perez GI, Blaser MJ, Holt PR. Increased gastric epithelial cell apoptosis associated with colonization with cagA + Helicobacter pylori strains. Cancer Res 2001; 61: 1406-1411
29. Kidd M, Lastovica AJ, Atherton JC, Louw JA. Conservation of the cag pathogenicity island is associated with vacA alleles and gastroduodenal disease in South African Helicobacter pylori isolates. Gut 2001; 49: 11-17
30. Nan HM, Park JW, Song YJ, Yun HY, Park JS, Hyun T, Youn SJ, Kim YD, Kang JW, Kim H. Kimchi and soybean pastes are risk factors of gastric cancer. World J Gastroenterol 2005; 11: 3175-3181
31. Franke A, Teyssen S, Singer MV. Alcohol-related diseases of the esophagus and stomach. Dig Dis 2005; 23: 204-213
32. Ladeiras-Lopes R, Pereira AK, Nogueira A, Pinheiro-Torres T, Pinto I, Santos-Pereira R, Lunet N. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control 2008; 19: 689-701
33. Khoury MJ, Wagener DK. Epidemiological evaluation of the use of genetics to improve the predictive value of disease risk factors. Am J Hum Genet 1995; 56: 835-844
34. Ottman R. An epidemiologic approach to gene-environment interaction. Genet Epidemiol 1990; 7: 177-185
35. Taioli E, Zocchetti C, Garte S. Models of interaction between metabolic genes and environmental exposure in cancer susceptibility. Environ Health Perspect 1998; 106: 67-70
36. Clayton D, McKeigue PM. Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet 2001; 358: 1356-1360
37. Hunter DJ. Gene-environment interactions in human dis-eases. Nat Rev Genet 2005; 6: 287-298
38. Rajaraman P, Hutchinson A, Rothman N, Black PM, Fine HA, Loeffler JS, Selker RG, Shapiro WR, Linet MS, Inskip PD. Oxidative response gene polymorphisms and risk of adult brain tumors. Neuro Oncol 2008; 10: 709-715
39. Bica CG, da Silva LL, Toscani NV, Zettler CG, Gottlieb MG, Alexandre CO, Graudenz MS, Mânica da Cruz IB. Polymorphism (ALA16VAL) correlates with regional lymph node status in breast cancer. Cancer Genet Cytogenet 2010; 196: 153-158
40. Zejnilovic J, Akev N, Yilmaz H, Isbir T. Association between manganese superoxide dismutase polymorphism and risk of lung cancer. Cancer Genet Cytogenet 2009; 189: 1-4
41. Wheatley-Price P, Asomaning K, Reid A, Zhai R, Su L, Zhou W, Zhu A, Ryan DP, Christiani DC, Liu G. Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma. Cancer 2008; 112: 1037-1042
42. Zhang Q, Li Y, Li X, Zhou W, Shi B, Chen H, Yuan W. PARP-1 Val762Ala polymorphism, CagA+ H. pylori infection and risk for gastric cancer in Han Chinese population. Mol Biol Rep 2009; 36: 1461-1467
43. Sutton A, Imbert A, Igoudjil A, Descatoire V, Cazanave S, Pessayre D, Degoul F. The manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and mRNA stability. Pharmacogenet Genomics 2005; 15: 311-319